Credit Suisses Neelkanth Mishra Sees Scope for Meaningful Rate Cuts DecadeLow Repo Rate Ahead Nationwide Faces Governance Concerns as Labour MP Raises Issues Before AGM BuzzBallz 99p Shot Faces Criticism from Alcohol Charities Over Youth Appeal Berkshire Hathaway Increases Alphabet Stake by 224 and Takes 26 Billion Position in Delta Air Lines Berkshire Hathaway Acquires 26 Billion Stake in Delta Air Lines Signaling Shift in Airline Sector Bet UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister PEP Q1 2026 Earnings EPS Beat by 281 Amid Mixed Signals Modiv Industrial Inc Class C MDV Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges Magnite MGNI Q1 2026 Earnings EPS Beats Expectations as AdTech Momentum Continues WU Q1 2026 Earnings EPS Falls Short of Estimates Stock Dips ADAM Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction RYAM Q1 2026 Earnings Significant EPS Miss Amid Stock Resilience Peoples Financial Services PFIS Holds Near Support Amid Modest Decline Pimco Global StocksPlus Income Fund PGP Edges Higher Amid Stabilizing Price Action Ulta Beauty ULTA Gains 22 as Retail Sector Holds Steady Key Levels to Watch Seaboard Corporation SEB Maintains Uptrend as Shares Hold Near 5083 Fangdd Network Group DUO Edges Higher as Stock Tests Key Resistance Zone Berkshire Hathaway Rebuilds Airline Exposure with 26 Billion Stake in Delta Air Lines CLNN Q1 2026 Earnings Significant EPS Beat Despite PreRevenue Status and Stock Decline Forestar Group Inc FOR Gains Momentum Testing Key Resistance Levels Harrow Inc HROW Q1 2026 Earnings Significant EPS Miss Amid Operating Challenges ACGLN Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Edges Higher UWMC Q1 2026 Earnings EPS Surprises to the Upside as Mortgage Market Stabilizes MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline Essential Utilities Q1 2026 Earnings EPS Falls Short of Estimates Good Times Restaurants Inc GTIM Q1 2026 Earnings Small Profit Reported Amid Limited Disclosure BMEA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline